Nektar Therapeutics has a promising lead drug candidate, but there is considerable risk involved. Madrigal Pharmaceuticals is generating strong revenue from a medicine with significant prospects.

Nektar Therapeutics just saw its fair value model refreshed, with the headline number holding steady at US$114.43 per share even as the long term revenue growth assumption for Rezpeg edged to a 10.83% ...

Nektar Therapeutics has a promising lead drug candidate, but there is considerable risk involved. Madrigal Pharmaceuticals is generating strong revenue from a medicine with significant prospects.

Nektar Therapeutics has a promising lead drug candidate, but there is considerable risk involved. Madrigal Pharmaceuticals is generating strong revenue from a medicine with significant prospects.

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also ...

Low-impact cardio exercises raise your heart rate without stressing your joints. Doing low-impact exercises can lower your risk of heart disease and type 2 diabetes. Common low-impact exercises ...

This January, Nekter Juice Bar is partnering with Koia, a leader in plant-based protein, to introduce a more functional approach to cleansing with the launch of its new Protein Cleanse featuring Koia ...

US EEOC scraps guidance that expanded workplace protections for LGBTQ workers The U.S. agency that enforces laws prohibiting workplace discrimination on Thursday rescinded legal guidance that had ...

Springer Nature is a signatory of the San Francisco Declaration on Research Assessment (DORA). Because small numbers of highly cited articles can have outsized influence on certain citation measures ...

Israel is to revoke the licences of 37 international non-governmental organisations (INGOs) working in Gaza and the occupied West Bank, saying they failed to meet requirements under new registration ...